Year-End Report 2017

2017 – An intense year during which we established the base for an aggressive market expansion!Q4 2017 · Net sales for the period amounted to SEK 0.8 (0.3) million. · Earnings for the period amounted to SEK -19.9 (-11.7) million, which corresponds to earnings per share of SEK -0.86 (-1.27). During the quarter a provision of SEK 2.3 million related to replacements of previous deliveries was made for some of the first commercial projects. · Cash and cash equivalents as at December 31 amounted to SEK 38.5 million. · During the quarter, ChromoGenics invoiced and completed